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Abstract
Acidic tissue microenvironment commonly exists in inflammatory diseases, tumors, ischemic organs, sickle cell disease, and
many other pathological conditions due to hypoxia, glycolytic cell metabolism and deficient blood perfusion. However, the
molecular mechanisms by which cells sense and respond to the acidic microenvironment are not well understood. GPR4 is a
proton-sensing receptor expressed in endothelial cells and other cell types. The receptor is fully activated by acidic
extracellular pH but exhibits lesser activity at the physiological pH 7.4 and minimal activity at more alkaline pH. To delineate
the function and signaling pathways of GPR4 activation by acidosis in endothelial cells, we compared the global gene
expression of the acidosis response in primary human umbilical vein endothelial cells (HUVEC) with varying level of GPR4.
The results demonstrated that acidosis activation of GPR4 in HUVEC substantially increased the expression of a number of
inflammatory genes such as chemokines, cytokines, adhesion molecules, NF-kB pathway genes, and prostaglandin-
endoperoxidase synthase 2 (PTGS2 or COX-2) and stress response genes such as ATF3 and DDIT3 (CHOP). Similar GPR4-
mediated acidosis induction of the inflammatory genes was also noted in other types of endothelial cells including human
lung microvascular endothelial cells and pulmonary artery endothelial cells. Further analyses indicated that the NF-kB
pathway was important for the acidosis/GPR4-induced inflammatory gene expression. Moreover, acidosis activation of GPR4
increased the adhesion of HUVEC to U937 monocytic cells under a flow condition. Importantly, treatment with a recently
identified GPR4 antagonist significantly reduced the acidosis/GPR4-mediated endothelial cell inflammatory response. Taken
together, these results show that activation of GPR4 by acidosis stimulates the expression of a wide range of inflammatory
genes in endothelial cells. Such inflammatory response can be suppressed by GPR4 small molecule inhibitors and hold
potential therapeutic value.
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Introduction
The induction of vascular endothelial cell inflammatory
responses is important for various pathophysiological conditions
[1,2,3,4]. For instance, the increased adhesiveness and inflamma-
tory cytokine production of endothelial cells play pivotal roles in
the recruitment of leukocytes to inflammatory sites. In this process,
leukocytes first adhere to the activated (inflamed) endothelial cells,
become stimulated, and then transmigrate through vascular
endothelium into inflammatory tissues. The increased production
of vascular adhesion molecules, chemokines and cytokines in
endothelial cells is critical for the endothelium-leukocyte interac-
tion [2]. Moreover, leukocyte infiltration is commonly observed in
solid tumors and is important for cancer progression and tumor
immunity [1]. Endothelial cell inflammatory responses also
promote the adherence of blood cells to vessel wall, which may
lead to vaso-occlusion and tissue ischemia as observed in stroke,
myocardial infarction, sickle cell disease, and many other diseases
[3,4]. It is, therefore, of significant importance to identify factors
and molecular pathways that regulate endothelial cell inflamma-
tory responses in order to devise new approaches to treat
inflammation and vaso-occlusion.
A myriad of studies show that localized interstitial acidosis is a
biochemical hallmark in inflammatory tissues, ischemic organs,
and solid tumors [5,6,7,8,9,10,11]. The acidification of local
tissues can be caused by dysregulated cell metabolism and/or
defective blood perfusion to remove acidic metabolic byproducts.
Using microelectrode or non-invasive imaging approaches, an
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interstitial tissue pH below 7.0, and sometimes even below 6.0, has
been observed in stroke, myocardial infarction, tumors, and
inflammatory diseases such as asthma and arthritis [6,8,10,12].
Interstitial acidosis has been shown to cause tissue injury and
aggravate disease progression [6,8,10]. Nevertheless, the effects of
acidosis on vascular endothelial cells and the molecular pathways
by which endothelial cells respond to acidosis are largely unknown.
Recent studies suggest that the proton-sensing receptor GPR4 is
a functional pH sensor for endothelial cells to perceive acidic
extracellular pH [13,14,15]. Our previous results show that
activation of GPR4 by either isocapnic acidosis or hypercapnic
acidosis (due to carbon dioxide accumulation) increases the
adhesiveness of HUVECs through the cAMP/Epac pathway
[13]. In the current study, we have used the whole-genome
transcriptomic analyses to assess the effects of acidosis activation of
GPR4 in human vascular endothelial cells. The results show that
activation of GPR4 by acidic pH augments the overall acidosis
response and particularly stimulates the expression of a wide range
of inflammatory genes. Importantly, treatment with a small
molecule inhibitor of GPR4 abolishes the acidosis/GPR4-medi-
ated endothelial inflammatory response, suggesting that targeting
GPR4 may be exploited as a potential approach to inhibit
inflammation and vaso-occlusion in various pathological condi-
tions.
Results
The global gene expression of GPR4-mediated acidosis
response in HUVEC
To examine the effects of acidosis/GPR4 signaling on gene
expression at the whole-genome level, we used microarrays to
compare the global gene expression response to acidosis in
HUVECs which had been stably transduced with either empty
vector (HUVEC/Vector cells) or human GPR4 cDNA (HUVEC/
GPR4 cells). The GPR4 mRNA level in HUVEC/GPR4 cells was
about 10-fold higher than that in HUVEC/Vector cells as
previously reported [13]. The overexpression of GPR4 is
potentially relevant as GPR4 expression can be up-regulated by
stimuli such as TNF-a and H2O2 in endothelial cells [16]. Previous
studies demonstrate that GPR4 has high receptor activity around
pH 6.4 (400 nM H+) and minimal activity around pH 8.4 (4 nM
H+) [13,15,17]. Therefore, HUVEC/Vector and HUVEC/GPR4
cells in four replicates were treated with pH 6.4 for 5 hours to
activate GPR4, and treated with pH 8.4 for 5 hours to serve as
negative controls. The same amount of Cy5-labeled sample cRNA
(from pH 6.4-treated cells) and Cy3-labeled control cRNA (from
pH 8.4-treated cells) of corresponding pairs of HUVEC was
hybridized with the Agilent Whole Genome Microarray Chip.
Since this is a dual-color array, the Cy5/Cy3 ratio of each gene
directly indicates the change in the expression in response to
acidosis. The normalized acidosis response were filtered using the
criteria of presence in .80% arrays with absolute variations of .3
fold in at least 3 arrays to select 1208 genes (Table S2). These
selected genes were then arranged by hierarchical clustering and
revealed that the overall acidosis response in HUVEC was greatly
enhanced by GPR4 overexpression (Fig. 1A).
Among the acidosis-induced genes, there were genes whose
induction was either dependent or independent of the varying
GPR4 levels. A few genes previously reported to be induced by
acidosis in breast cancer cells [18], including TXNIP, ARRDC4
and EGR2, were also noted to be induced in both HUVEC/
Vector and HUVEC/GPR4 cells (Fig. 1A). However, some
acidosis-induced genes were either increased by several-fold or
unchanged in the control HUVEC/Vector cells but significantly
further induced in HUVEC/GPR4 cells (Fig. 1A). These genes
include many inflammatory genes (e.g. CXCL2, CCL20, IL8,
TRAF1, RELB, CD69, SELE, VCAM1 and PTGS2) and stress
response genes (e.g. ATF3, ATF4, DDIT3 and ASNS). Similarly,
a small set of genes were repressed in both HUVEC/Vector and
HUVEC/GPR4 cells, including N-myc, GADD45G, and
CXCR4. The reduction of some genes, such as E2F2, HK2
(hexokinase 2), and AKT2, however, were greatly enhanced by a
higher level of GPR4 in HUVEC/GPR4 cells. The repression of
AKT2 and HK2 is consistent with a previous report on the ability
of acidosis to repress AKT and glycolysis in breast cancer cells
[19].
To formally define the gene expression program regulated by
GPR4, we used SAM (Significance Analysis of Microarrays) [20]
to identify the subsets of genes whose expression was significantly
altered by the varying level of GPR4 between HUVEC/Vector
cells and HUVEC/GPR4 cells. We selected 941 and 679 genes
which were either induced or repressed, respectively, by GPR4
overexpression at 0% false discovery rate (Table S3 and Table S4).
When the expression of the SAM selected gene lists were
examined in the context of HUVEC acidosis response, we found
that the expression of most genes induced by GPR4 overexpres-
sion was increased by acidic pH (Fig. 1B). Among the 941 induced
probes selected by SAM, 908 (at P,0.05) and 840 (at P,0.01)
probes were statistically higher in the GPR4-overexpressing cells,
respectively. Moreover, the expression of most genes repressed by
GPR4 overexpression was decreased by acidic pH (Fig. 1C).
Among the 679 repressed probes selected by SAM, 670 (at
P,0.05) and 636 (at P,0.01) probes were statistically lower in the
GPR4-overexpressing cells, respectively. The Gene Ontology
(GO) enrichment was performed for the genes that were induced
by GPR4 overexpression in HUVEC/GPR4 cells using the
GATHER program [21], and found that immune, defense and
inflammatory responses were significantly enriched (Table S5). In
contrast, the DNA-dependent transcription and nucleotide
metabolism were enriched for the genes that were repressed by
GPR4 overexpression (Table S6). These results were consistent
with the GPR4-dependent induction of the inflammatory response
(Table 1). Together, these data show a convincing and critical role
of GPR4 in the acidosis gene expression response of HUVEC.
The GPR4-mediated induction of inflammatory genes in
HUVEC
The inflammatory genes with substantial up-regulation by the
acidosis/GPR4 signaling include: chemokines and cytokines
(CXCL1, CXCL2, CXCL3, CXCL6, CX3CL1, CCL2, CCL5,
CCL7, CCL20, CSF2, IL1A, IL8), adhesion molecules (E-selectin
(SELE), VCAM1, ICAM1), several genes involved in the TNF
pathway (TNFRSF9, TNFSF7, TRAF1, TNFAIP2, TNFAIP3,
TNFAIP8, TNIP3) and the NF-kB pathway (NFKB1, NFKB2,
RELB, NFKBIA, NFKBIZ), the inflammatory enzyme prosta-
glandin-endoperoxidase synthase PTGS2 (COX-2), transcription
factors early growth response (EGR) 1, 2 and 3, and TXNIP.
We then further assessed the GPR4-mediated induction of the
inflammatory genes which represent a prominent signature in our
microarray dataset. For the majority of the inflammatory genes,
GPR4 overexpression further augmented their up-regulation by
acidic pH in HUVECs (Table 1). For instance, the expression of
IL8 was increased by 6.9 fold in HUVEC/Vector cells and 50.4
fold in HUVEC/GPR4 cells by pH 6.4 in comparison to pH 8.4.
The results indicate that these genes are directly induced by
acidosis/GPR4 signaling. For few genes, such as EGR2 and
TXNIP, the fold of up-regulation responding to acidosis was
similar in HUVEC/Vector and HUVEC/GPR4 cells (Table 1),
GPR4 and Endothelial Cell Inflammation
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suggesting that the induction of these genes is through GPR4-
independent mechanisms.
Validation of the differential gene expression identified
by the microarray analysis
TapMan real-time RT-PCR was performed to confirm the
expression of a number of genes induced by acidosis/GPR4. Total
RNA was isolated from HUVEC/Vector and HUVEC/GPR4
cells that were treated with pH 6.4 (400 nM H+), pH 7.4 (40 nM
H+), or pH 8.4 (4 nM H+) for 5 hours. After normalized to the
internal control GAPDH gene, the fold change of gene expression
was calculated by the 22DDCt method [22]. Normalization to two
other housekeeping genes, b-actin and 18S rRNA, gave similar
results. We have confirmed the expression of 18 genes. The
representative real-time RT-PCR results of 6 genes are shown in
Fig. 2. Table S7 includes the quantitative gene expression changes
of all 18 genes including CXCL2, CCL20, VCAM1, E-selectin,
ICAM1, CD69, IL8, IL1A, PTGS2 (COX-2), RELB, TRAF1,
EGR1, EGR2, EGR3, DDIT3 (CHOP), FOXF1, ATF3 and
KLF9 (Table S7). Overall, the real-time RT-PCR results were
consistent with the microarray results. Compared to the physio-
logical pH 7.4 and basic pH 8.4, the acidic pH 6.4 increased the
expression of these genes in HUVECs. Moreover, the overex-
pression of GPR4 further stimulated the expression of the majority
Figure 1. The global gene expression of acidosis response of HUVEC. (A) The gene expression response of HUVECs transduced with the
control vector or the GPR4 expression construct is shown. 1208 probes were selected by the criteria of at least three observations with at least three
fold changes and arranged by hierarchical clustering. Clusters of genes which are induced or repressed in a GPR4-depedent or -independent fashion
are shown with the names of selected genes. (B, C) The gene expression responses of the probes selected by SAM to be 941 GPR4-induced (B) or 679
GPR4-repressed (C) are depicted with the names of selected genes shown.
doi:10.1371/journal.pone.0061991.g001
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of these genes in response to acidosis in HUVEC/GPR4 cells,
suggesting that these genes are regulated by acidosis/GPR4
signaling. To further validate the gene expression at the protein
level, we performed Western blotting to examine the expression of
DDIT3 (CHOP) and PTGS2 (COX-2) in HUVEC. The results
showed that acidic pH treatment increased the protein expression
of DDIT3 and PTGS2 in HUVEC/Vector cells, which was
further increased in HUVEC/GPR4 cells (Fig. 3). The induced
expression of PTGS2 (COX-2) by acidic pH is concordant with a
previous study using bovine corneal endothelial cells [23].
Our previous studies demonstrate that hypercapnic acidosis,
similar as isocapnic acidosis, can activate GPR4 to increase the
expression of adhesion molecules (E-selectin, VCAM-1 and
ICAM-1) and the adhesiveness of HUVEC [13]. Here we
examined whether hypercapnic acidosis could stimulate the
expression of other inflammatory genes identified by the
microarray analyses. As shown in Fig. 4, hypercapnic acidosis
treatment of HUVEC/Vector cells induced the gene expression of
CXCL2, CCL20, IL8, and CD69, and the increase of expression
was further augmented by GPR4 overexpression in HUVEC/
GPR4 cells, showing a similar pattern as the effects of isocapnic
acidosis on HUVEC. However, there were some differences as
well. For example, hypercapnic acidosis failed to increase the
expression of PTGS2 in HUVEC/Vector cells; gene expression
level was actually even lower upon hypercapnic acidosis (20%
CO2) treatment compared to the ambient air treatment (Fig. 4E).
But the overexpression of GPR4 could still increase PTGS2
expression upon hypercapnic acidosis in HUVEC/GPR4 cells.
The reason why the expression of PTGS2 in HUVEC at alkaline
pH (ambient air treatment) is higher than that at pH 7.4 (5%
CO2) is currently unknown. The expression of IL1A was induced
by hypercapnic acidosis in HUVEC/GPR4 cells but unchanged in
HUVEC/Vector cells (Fig. 4D).
Acidosis activation of GPR4 also stimulates inflammatory
gene expression in human lung microvascular
endothelial cells and human pulmonary artery
endothelial cells
As different types of vascular endothelial cells may exhibit
different biological responses [24], we examined whether activa-
tion of GPR4 by acidosis can increase the expression of
inflammatory genes in other endothelial cells in addition to
HUVEC. As shown by RT-PCR (Fig. S1A), GPR4 was the
predominant member of the proton-sensing GPCRs expressed in
HUVEC, primary human pulmonary artery endothelial cells
(HPAEC) and human lung microvascular endothelial cells
(HMVEC-L). Other proton-sensing GPCRs, including TDAG8
(GPR65), OGR1 (GPR68) and G2A (GPR132), were expressed at
very low level in these endothelial cells. Compared to GPR4
expression in HUVEC (set as 100%), real-time RT-PCR showed
that GPR4 was expressed in HPAEC and HMVEC-L at the level
of,120% and,47%, respectively (Fig. S1B). Attempts were made
to detect the protein expression of GPR4 by Western blotting,
immunofluorescence, and flow cytometry using several commer-
cially available GPR4 antibodies; however, we have not yet been
able to obtain definitive GPR4-specific signals using these
antibodies. This represents a limitation for the GPR4 study.
HPAEC and HMVEC-L were treated with pH 8.4 (4 nM H+),
pH 7.4 (40 nM H+), or pH 6.4 (400 nM H+) for 5 hours, and the
expression of several inflammatory genes was assessed. The results
showed that, in comparison to pH 8.4 and 7.4, pH 6.4 stimulated
the expression of these inflammatory genes except for ICAM-1 in
HPAEC and HMVEC-L (Fig. S2). This observation is in
accordance with the results in HUVEC. Interestingly, the basal
expression level of the inflammatory genes was higher in
HMVEC-L than that in HPAEC. However, the fold of increase
in gene expression was larger in HPAEC than that in HMVEC-L
(Fig. S2). This is consistent with the higher expression level of
GPR4 in HPAEC (Fig. S1B).
To investigate whether overexpression of GPR4 can further
increase the expression of the inflammatory genes in response to
acidosis, HPAEC and HMVEC-L were stably transduced with
human GPR4 cDNA or the MSCV-IRES-GFP vector control. As
shown in Fig. 5, upon acidosis treatment, HPAEC/Vector cells
showed a similar extent of up-regulation of the inflammatory genes
expression as HPAEC parental cells did (Fig. S2), while HPAEC/
GPR4 cells, with GPR4 overexpression, showed a much stronger
up-regulation of those inflammatory genes (Fig. 5). Similar results
were observed in HMVEC-L/Vector and HMVEC-L/GPR4 cells
Table 1. A partial list of acidosis/GPR4-induced inflammatory
genes by microarray analysis.
Gene ID Gene Symbol Fold Changes (average)
Vector* (pH 6.4/
pH 8.4)
GPR4* (pH 6.4/
pH 8.4)
3576 IL8 6.9 50.4
6354 CCL7 4.4 16.2
6372 CXCL6 3.8 15.0
2920 CXCL2 3.2 103.7
2919 CXCL1 2.9 40.0
1437 CSF2 2.9 9.3
6376 CX3CL1 2.8 17.3
2921 CXCL3 2.4 43.6
6364 CCL20 2.3 78.2
6347 CCL2 2.1 25.8
6352 CCL5 1.6 16.8
3552 IL1A 1.2 19.1
7412 VCAM1 6.5 65.9
6401 SELE 2.5 125.3
3383 ICAM1 1.3 7.7
3604 TNFRSF9 1.6 5.5
79931 TNIP3 1.5 21.3
7128 TNFAIP3 1.4 31.2
7127 TNFAIP2 1.4 10.5
5971 RELB 1.4 6.4
25816 TNFAIP8 1.3 9.7
970 TNFSF7 1.3 8.0
4792 NFKBIA 1.2 8.9
7185 TRAF1 1.1 8.2
64332 NFKBIZ 1.0 6.2
1958 EGR1 12.6 32.7
1959 EGR2 14.6 14.0
1960 EGR3 1.5 6.1
10628 TXNIP 6.6 6.3
5743 PTGS2 1.3 17.8
*Vector: HUVEC/Vector cells, pH 6.4 vs. 8.4; GPR4: HUVEC/GPR4 cells, pH 6.4 vs.
8.4.
doi:10.1371/journal.pone.0061991.t001
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(Fig. 5). Taken together, these results suggest that acidosis also
stimulates GPR4 to increase the expression of inflammatory genes
in human pulmonary artery endothelial cells and human lung
microvascular endothelial cells.
The NF-kB pathway is important for acidosis/GPR4-
induced inflammatory gene expression in endothelial
cells
As the microarray analysis showed that several genes in the NF-
kB pathway were up-regulated by acidosis activation of GPR4 in
HUVECs, we investigated whether the NF-kB pathway was
important for the acidosis/GPR4-induced inflammatory gene
expression. Western blotting analysis showed that acidosis
stimulation of GPR4 quickly increased the phosphorylation of
IkB-a in HUVECs within 3 minutes (Fig. 6A), indicating the
activation of the NF-kB pathway [25]. Furthermore, HUVEC/
Vector and HUVEC/GPR4 cells were treated with two different
NF-kB inhibitors: BAY11-7082 that inhibits IkB-a phosphoryla-
tion and the IKK inhibitor VII. Treatment with NF-kB inhibitors
substantially abolished the acidosis/GPR4-induced inflammatory
gene expression in HUVEC/Vector and HUVEC/GPR4 cells in
a dose-dependent manner (Fig. 6 and Fig. S3), suggesting an
important role for the NF-kB pathway in this process. Notably,
compared to VCAM1, SELE, and CXCL2, the expression of IL8
was less sensitive to the BAY11-7082 inhibition especially in
HUVEC/Vector cells (Fig. 6D), suggesting that other pathways
besides NF-kB might also be important for IL8 expression [26].
Figure 2. Validation of microarray by real-time RT-PCR. HUVECs transduced with the control vector (Vector, white bars), or the GPR4
expression construct (GPR4, dark bars) were treated with EGM-2/HEM media at pH 8.4, 7.4, or 6.4 for 5 h. Total RNA was isolated and cDNA was
synthesized. Real-time RT-PCR quantification of mRNA levels of CXCL2 (A), CCL20 (B), IL8 (C), PTGS2 (D), RELB (E) and TRAF1 (F) was performed. Ct
values were normalized to the housekeeping gene GAPDH. The expression level of the target gene in HUVEC/Vector or HUVEC/GPR4 cells at pH 8.4
was set as 1. Error bars indicate the mean 6 SEM. *, P,0.05; **, P,0.01; ***, P,0.001; ns, not significant (P.0.05); compared with the pH 8.4 groups.
The results shown are the average of at least two biological repeats.
doi:10.1371/journal.pone.0061991.g002
GPR4 and Endothelial Cell Inflammation
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Acidosis/GPR4-induced endothelial cell inflammation
enhances the binding with U937 monocytes under a flow
condition
The microarray and real-time PCR results showed that
activation of GPR4 by acidosis stimulated the expression of a
number of inflammatory adhesion molecules and chemokines
(Table 1). Therefore, we examined whether acidosis/GPR4-
induced endothelial cell inflammation would increase the binding
with U937 monocytes under a flow condition at the wall shear
stress of 0.5 dyne/cm2. For HUVECs treated with pH 8.4 and
pH 7.4, there was little firm adhesion or rolling of U937
monocytes under the flow condition. In comparison, U937
monocytes showed increased rolling and adherence to pH 6.4-
treated HUVEC/Vector cells and this effect was substantially
further enhanced in pH 6.4-treated HUVEC/GPR4 cells (Fig. 7
and Videos S1–S6). These observations from the flow chamber
assay were concordant with our previous static cell adhesion
findings [13]. Together, the results show that acidosis activation of
GPR4 in HUVECs augments the binding to U937 monocytes.
Inhibition of GPR4 by its antagonist attenuates acidosis-
induced endothelial cell inflammation
A group of imidazo-pyridine derivatives were recently identified
as GPR4 antagonists that inhibit GPR4 activities [27]. However,
the effects of the GPR4 inhibitors on endothelial cell inflammation
have not been examined. We assessed the biological effects of one
of the antagonist compounds, 2-Ethyl-3-{4-[(E)-3-(4-isopropyl-
piperazin-1-yl)-propenyl]-benzyl}-5,7-dimethyl-3H-imidazo[4,5-
b]pyridine (abbreviated as EIDIP), in our study. We first examined
whether EIDIP can inhibit the acidosis/GPR4-mediated cAMP
production in endothelial cells. HUVEC/Vector and HUVEC/
GPR4 cells were treated with varying pH in the presence or
absence of the GPR4 antagonist EIDIP. Compared to pH 8.4 and
7.4, pH 6.4 increased intracellular cAMP accumulation by,2 fold
and,10 fold in HUVEC/Vector and HUVEC/GPR4 cells,
respectively. The treatment with EIDIP significantly inhibited the
acidosis/GPR4-induced cAMP accumulation (Fig. 8). Further-
more, we showed that the treatment of the GPR4 inhibitor
diminished the acidosis/GPR4-induced inflammatory gene ex-
pression in HUVEC/Vector and HUVEC/GPR4 cells in a dose-
dependent manner (Fig. 9A–9E). The GPR4 inhibitor treatment
also decreased the acidosis/GPR4-induced HUVEC adhesiveness
as measured by the U937 cell adhesion assay (Fig. 9F). These
results suggest that inhibition of GPR4 by its antagonist can
attenuate acidosis-stimulated endothelial cell inflammation.
Discussion
The major findings of this study are that acidosis activation of
the proton-sensing receptor GPR4 stimulates a broad inflamma-
tory response in human vascular endothelial cells and the
treatment with a recently identified inhibitor of GPR4 can
effectively suppress this inflammatory response. These results
indicate that the acidosis/GPR4 receptor signaling is a novel
pathway in endothelial cell inflammatory response, which is a
crucial component in many pathological conditions such as
inflammation, ischemia, sickle cell disease, tumor, metabolic
diseases, renal diseases, and respiratory diseases [1,2,3,4,28]. This
aspect of biology is very relevant because local or systemic acidosis
is a hallmark of tissue microenvironment in these diseases
[6,8,10,12,29].
Numerous studies have shown that tissue acidity aggravates
organ injury and exacerbates the progression of acidosis-associated
diseases such as ischemic diseases and sickle cell disease [8,10,30].
In ischemic heart disease and stroke, inflammation plays a pivotal
role in promoting tissue damage after ischemia and reperfusion.
Leukocyte infiltration is commonly observed in ischemic tissues,
and reactive oxygen species and proteolytic enzymes produced by
leukocytes are important mediators of tissue damage [31,32].
Leukocyte adhesion to the microvasculature is rapidly enhanced
during the reperfusion process [33]. Leukocyte and platelet
intravascular plugging may play a role in the ‘‘no reflow’’
phenomenon following blood reperfusion [34]. Based on our
results, it is tempting to speculate that acidosis/GPR4-induced
endothelial cell adhesion and inflammatory response may increase
the recruitment and activation of leukocytes in ischemic tissues
and may also contribute to vaso-occlusion and the ‘‘no reflow’’
phenomenon after reperfusion. As another example, acidosis is a
well-known risk factor that increases the incidence of sickle cell
crisis and vaso-occlusive events in sickle cell disease [30,35,36,37].
Previous studies show that acidosis increases red cell sickling and
dense sickle erythrocyte formation [30,35]. However, this may not
be the only mechanism responsible for vaso-occlusion. In fact, our
results suggest a potential novel mechanism by which acidosis
aggravates sickle cell crisis; that is, acidosis activates the proton-
sensing GPR4 receptor to stimulate endothelial cell inflammatory
response and thus increases blood cell attachment and vaso-
occlusion. Concordant with this thought, endothelial cell inflam-
mation is correlated with an increased risk of stroke and occlusive
disease at the circle of Willis in sickle cell patients [38].
Acidosis activation of the GPR4 receptor in vascular endothelial
cells modulates the expression of a large number of genes involved
in various biological pathways, such as inflammation, endoplasmic
reticulum (ER) stress response, and cell metabolism. In line with
our observations, a recent study shows that lactic acidosis induces
inflammatory response and ER stress response in breast cancer
cells [9], although many of the up-regulated target genes are
different between endothelial cells and breast cancer cells. Our
results provide evidence that the proton-sensing GPCRs are
involved in acidosis-induced ER stress response, a process closely
related to inflammation [39]. Moreover, two earlier studies show
that chronic acidosis treatment regulates the expression of genes
involved in cell metabolism in renal cells and intestinal cells
[40,41]. All these studies suggest some common features of acidosis
Figure 3. Validation of gene expression at the protein level by
Western blotting. HUVEC/Vector and HUVEC/GPR4 cells were treated
with EGM-2/HEM media at pH 8.4, 7.4, or 6.4 for 5 h. Cells were then
lysed with RIPA buffer, and total proteins were separated by
electrophoresis and transferred to nitrocellulose membrane. Protein
expression of DDIT3 (CHOP) and PTGS2 (COX-2) was detected using the
specific antibodies. The target bands are indicated by an arrow. Western
blot of GAPDH serves as a loading control. The results shown are
representative of three experiments.
doi:10.1371/journal.pone.0061991.g003
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responses in various cell types. On the other hand, certain acidosis
responses are particularly prominent in a cell type-specific
manner. For instance, the up-regulation of inflammatory chemo-
kines, cytokines and adhesion molecules are particularly strong in
vascular endothelial cells that we have studied. Our results also
indicate that the proton-sensing GPCRs, such as GPR4, can at
least partly mediate the acidosis-induced cell responses.
Acidosis/GPR4-mediated inflammatory gene expression ap-
pears to be general in several types of vascular endothelial cells. In
addition to HUVEC, human lung microvascular endothelial cells
and human pulmonary artery endothelial cells can also be
stimulated by acidosis to up-regulate inflammatory molecules.
Genetic overexpression of GPR4 in these endothelial cells
substantially further increases the acidosis-induced inflammatory
gene expression. These results show that the activation of GPR4
by acidosis triggers a pro-inflammatory signal cascade in
endothelial cells. In the literature, the effects of acidosis on
vascular endothelial cells remain largely unclear and, in some
cases, opposite effects have been reported. For instance, a previous
study shows that hypercapnic acidosis decreases the lipopolysac-
charide-induced ICAM-1 expression in human pulmonary artery
endothelial cells [42]. On the other hand, a more recent study
observes the opposite effects and shows that hypercapnic acidosis
increases the lipopolysaccharide-induced expression of ICAM-1,
Figure 4. Hypercapnic acidosis activation of GPR4 increases the expression of inflammatory genes in HUVEC. HUVECs transduced with
the control vector (Vector, white bars), or GPR4 expression construct (GPR4, dark bars) were treated for 5 h with EGM-2 media buffered with ambient
air, 5% CO2 or 20% CO2. Real-time RT-PCR quantification of mRNA levels of CXCL2 (A), CCL20 (B), IL8 (C), IL1A (D), PTGS2 (E), and CD69 (F) was
performed. Ct values were normalized to the housekeeping gene GAPDH. The expression level of the target genes in HUVEC/Vector or HUVEC/GPR4
cells treated with ambient air-buffered EGM-2 medium was set as 1. Error bars indicate the mean 6 SEM. *, P,0.05; **, P,0.01; ***, P,0.001; ns, not
significant (P.0.05); compared with the ‘ambient air’ groups. The results shown are the average of two biological repeats.
doi:10.1371/journal.pone.0061991.g004
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VCAM-1 and E-selectin in human lung microvascular endothelial
cells [43]. In our current study, the unbiased genome-wide
microarray analysis clearly demonstrates that acidosis activation of
GPR4 in endothelial cells induces the expression of a broad range
of inflammatory genes including adhesion molecules, chemokines
and cytokines. For ICAM-1 in particular, acidic pH did not
significantly affect its expression in the vector control endothelial
cells but still substantially increased the expression of ICAM-1 in
GPR4-overexpressing cells, indicating that ICAM-1 is also an
acidosis/GPR4-induced gene. Overall, our data strongly suggest
that acidosis activation of GPR4 stimulates a pro-inflammatory
response in vascular endothelial cells.
As the interaction between endothelial cells and blood cells is
critical for inflammation and vaso-occlusion, targeting endothelial
cell inflammation has been exploited as a strategy for the
treatment of inflammatory diseases and vaso-occlusive diseases.
For example, antibodies and small molecules targeting endothelial
cell adhesion molecules have been tested for the treatment of
inflammation, sickle cell disease, stroke and ischemic heart disease
[2,3,4,44]. GPR4 may serve as a novel target for the inhibition of
endothelial cell inflammatory response. In this respect, our results
Figure 5. Isocapnic acidosis activation of GPR4 also increases the expression of inflammatory genes in HPAEC and HMVEC-L. HPAEC
or HMVEC-L cells were transduced with the control vector or the GPR4 expression construct (designated as HPAEC/Vector (N), HPAEC/GPR4 (&),
HMVEC-L/Vector (m), and HMVEC-L/GPR4 (.)). HPAEC or HMVEC-L cells were then treated with EGM-2/HEM or EGM-2-MV/HEM media at pH 8.4, 7.4,
or 6.4 for 5 h, respectively. Real-time RT-PCR quantification of mRNA levels of VCAM1 (A), SELE (B), ICAM1 (C), IL8 (D), CXCL2 (E) and CCL20 (F) was
performed. The expression level of the target genes in above-mentioned cells at pH 8.4 was set as 1. Error bars indicate the mean 6 SEM. *, P,0.05;
**, P,0.01; ***, P,0.001; comparing pH 6.4 to pH 8.4 in HPAEC cells. #, P,0.05; ##, P,0.01; ###, P,0.001; comparing pH 6.4 to pH 8.4 in
HMVEC-L cells. The results shown are the average of at least two biological repeats.
doi:10.1371/journal.pone.0061991.g005
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show that a recently identified GPR4 inhibitor can suppress the
acidosis-induced inflammatory gene expression in endothelial cells.
We have also previously shown that inhibition of GPR4 by small
interfering RNAs attenuates acidosis-induced endothelial cell
adhesion [13]. Furthermore, our results suggest that the NF-kB
pathway is important for the acidosis/GPR4-induced inflamma-
tory gene expression in endothelial cells. In complex diseases such
as chronic inflammation and sickle cell disease, many pathogenic
factors are involved. Effective, chronic medication with minimal
side effect is highly desirable for the management of this type of
disease. With this regard, GPR4 represents a potential therapeutic
target whose inhibition may have acceptable safety profile since
the phenotype of GPR4-deficient mice is mild compared to the
knockout phenotype of some critical regulators of inflammation
Figure 6. NF-kB pathway is involved in acidosis/GPR4-induced inflammatory response. (A) Western blot of phosphorylated IkB-a
expression in HUVEC/Vector and HUVEC/GPR4 cells. Cells were pretreated with EGM-2/HEM pH 8.4 medium for 4 h, followed by the treatment with
EGM-2/HEM media at pH 8.4, 7.4, or 6.4 for 3 min. The target bands are indicated by an arrow. Western blot of GAPDH serves as a loading control. (B–
E) HUVEC/Vector or HUVEC/GPR4 cells were treated for 5 h with EGM-2/HEM pH 8.4, 7.4 or 6.4 media, or with pH 6.4 media containing indicated
concentrations of NF-kB inhibitor BAY 11-7082. Total RNA was isolated and cDNA was synthesized. Real-time RT-PCR quantification of gene
expression of VCAM1 (B), SELE (C), IL8 (D) and CXCL2 (E) was performed. Ct values were normalized to the housekeeping gene GAPDH. The
expression level of the target genes at pH 8.4 was set as 1. Error bars indicate the mean 6 SEM. *, P,0.05; **, P,0.01; ***, P,0.001; compared with
the pH 6.4 vehicle control in HUVEC/Vector cells. #, P,0.05; ##, P,0.01; ###, P,0.001; compared with the pH 6.4 vehicle control in HUVEC/GPR4
cells. The results shown are the average of at least three biological repeats.
doi:10.1371/journal.pone.0061991.g006
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[45,46]. However, it should be noted that GPR4-null mice have
minor defects in renal acid excretion and mild metabolic acidosis
[47]. A small fraction of GPR4-null mice exhibit a partially
penetrant phenotype of perinatal mortality in a mixed B6/129
genetic background [15]. GPR4 deficiency also affects the quality
of small blood vessels during angiogenesis [14,15]. Nonetheless,
Figure 7. Increased binding of U937 monocytes to vascular endothelial cells treated with acidic pH. (A) U937 monocytic cells were
adherent to acidic pH-treated HUVEC/GPR4 cells under a flow condition. Representative pictures are shown with the adhered U937 cells indicated by
arrows. (B) HUVECs stably overexpressing GPR4 or control vector were grown to a monolayer, and were treated with EGM-2/HEM pH 8.4, 7.4 or 6.4
media for 5 h. U937 monocytes were adhered to the pH-treated HUVEC monolayer under a flow condition (0.5 dyne/cm2). Error bars indicate the
mean 6 SEM. ***, P,0.001; compared with the pH 8.4 groups. The results represent the average of cell counts from 6 fields.
doi:10.1371/journal.pone.0061991.g007
Figure 8. Inhibition of acidosis/GPR4-induced cAMP production by the GPR4 antagonist in HUVEC. (A–B) HUVEC/Vector and HUVEC/
GPR4 cells were treated with varying pH in the presence or absence of the GPR4 antagonist EIDIP. After the pH treatment, intracellular cAMP was
measured as described in the Materials and Methods. The vehicle control had 0.04% DMSO which is the same DMSO concentration as that in 20 mM
GPR4 antagonist. The results are the average of 10 samples for HUVEC/Vector cells and 7 samples for HUVEC/GPR4 cells. Error bars indicate the mean
6 SEM. **, P,0.01; ***, P,0.001; ns, not significant.
doi:10.1371/journal.pone.0061991.g008
GPR4 and Endothelial Cell Inflammation
PLOS ONE | www.plosone.org 10 April 2013 | Volume 8 | Issue 4 | e61991
Figure 9. Inhibition of GPR4 activation by its antagonist attenuates the expression of inflammatory genes. (A–E) HUVEC/Vector or
HUVEC/GPR4 cells were treated for 5 h with EGM-2/HEM pH 8.4, 7.4 or 6.4 media, or with pH 6.4 media containing indicated concentrations of GPR4
antagonist. Total RNA was isolated and cDNA was synthesized. Real-time RT-PCR quantification of gene expression of VCAM1 (A), SELE (B), ICAM1 (C),
IL8 (D) and CXCL2 (E) was performed. The expression level of the target gene in HUVECs at pH 8.4 was set as 1. Error bars indicate the mean6 SEM. *,
P,0.05; **, P,0.01; ***, P,0.001; compared with the pH 6.4 vehicle control in HUVEC/Vector cells. #, P,0.05; ##, P,0.01; ###, P,0.001;
compared with the pH 6.4 vehicle control in HUVEC/GPR4 cells. The results shown are the average of at least two biological repeats. (F) HUVECs
stably overexpressing GPR4 were grown to form a monolayer. Cells were then pretreated with vehicle or GPR4 antagonist (at indicated
concentrations) for 1 h, followed by the treatment with indicated pH media or pH 6.4 medium containing indicated concentrations of GPR4
antagonist for 5 h. The static cell adhesion assay was then performed using U937 monocyte binding as a functional readout as previously described
[13]. Error bars indicate the mean 6 SEM. *, P,0.05; **, P,0.01; compared with the pH 6.4 vehicle group. The results represent the average of cell
counts from 3 fields under an inverted microscope (total 1006magnification).
doi:10.1371/journal.pone.0061991.g009
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future research is warranted to validate GPR4 as a potential
therapeutic target for inhibiting inflammation and vaso-occlusion
in acidosis-associated diseases. Plausibly, combination therapy that
targets multiple molecular pathways with acceptable drug safety
profile is needed to treat complex diseases such as inflammatory
and vaso-occlusive disorders. GPR4 inhibitors may be exploited as
potential novel agents to suppress vascular inflammatory respons-
es.
Materials and Methods
Chemicals and reagents
Real-time PCR reagents were purchased from Applied Biosys-
tems Inc (ABI, Foster City, CA). 4-(2-hydroxyethyl)-1-piperazi-
neethanesulfonic acid (HEPES), N-(2-hydroxyethyl)-piperazine-N’-
3-propanesulfonic acid (EPPS), 2-(4-morpholino)-ethanesulfonic
acid (MES), and protease inhibitor cocktail were from Sigma-
Aldrich (St Louis, MO) and Fisher Scientific (Fair Lawn, NJ). BAY
11-7082 and IKK inhibitor VII were purchased from Calbio-
chem/EMD4Biosciences (La Jolla, CA). GPR4 antagonist, 2-
Ethyl-3-{4-[(E)-3-(4-isopropyl-piperazin-1-yl)-propenyl]-benzyl}-
5,7-dimethyl-3H-imidazo[4,5-b]pyridine, was purchased from
Dalton Pharma Services (Toronto, Canada). The Amersham
cAMP Biotrak Enzymeimmunoassay (EIA) kit was purchased from
GE Healthcare Life Sciences. 0.1% gelatin in ultrapure water was
from Millipore (Billerica, MA). Monoclonal antibodies for
phosphorylated IkB-a (Ser32) (clone 14D4) and GAPDH (clone
14C10) were from Cell Signaling Technology (Danvers, MA).
Polyclonal antibodies for DDIT3 (a.k.a. GADD 153, CHOP) and
PTGS2 (COX-2) were from Santa Cruz Biotechnology (Dallas,
TX).
Cell culture and retroviral transduction
Cells were cultured in a humidified tissue culture incubator
filled with 5% CO2 and 95% air at 37 uC. Primary human
umbilical vein endothelial cells (HUVEC), human lung microvas-
cular endothelial cells (HMVEC-L) and human pulmonary artery
endothelial cells (HPAEC) were purchased from Lonza (Walkers-
ville, MD). HUVECs and HPAECs were grown in endothelial cell
growth medium 2 (EGM-2), and HMVEC-Ls were grown in
EGM-2-MV medium (Lonza). The construction of the MSCV-
huGPR4-IRES-GFP plasmid and the retroviral transduction of
HUVEC, HPAEC or HMVEC-L cells were performed as
previously described [5,13]. Human endothelial cells stably
expressing the MSCV-IRES-GFP or MSCV-huGPR4-IRES-
GFP construct were isolated by fluorescence-activated cell sorting
(FACS) based on green fluorescence signals.
Isocapnic and hypercapnic pH treatment
The preparation of isocapnic pH media was carried out as
previously described [13]. Briefly, EGM-2 or EGM-2-MV media
were buffered with 7.5 mM HEPES, 7.5 mM EPPS and 7.5 mM
MES (abbreviated as HEM), and the pH was adjusted using
NaOH or HCl and measured with an electronic pH meter
(Fisher). To prepare hypercapnic pH media, regular EGM-2
medium was added in cell culture plates and incubated overnight
in humidified tissue culture incubators with ambient air, 5% CO2
or 20% CO2, respectively. The pH of the media pre-treated under
these conditions was measured to be around 8.4, 7.4 and 6.4,
respectively. Before the pH treatment, human endothelial cells
were cultured in 10-cm plates, 6-cm plates or 6-well plates to reach
50–90% confluency. To perform isocapnic pH treatment,
endothelial cells were incubated for 5–6 hours in the EGM-2/
HEM, or EGM-2-MV/HEM media at varying pH in a regular
tissue culture incubator with 5% CO2. To perform hypercapnic
pH treatment, endothelial cells were treated with CO2-buffered
EGM-2 media for 5–6 hours in tissue culture incubators with 20%
CO2 and with ambient air and 5% CO2 as controls. When an
inhibitor or antagonist was used, cells were pretreated with regular
growth medium containing indicated concentrations of inhibitor
or antagonist for 1 hour, followed by 5 hours of pH treatment
with HEM-buffered growth medium containing same concentra-
tions of inhibitor or antagonist.
Microarray hybridization and analysis
Microarray was performed on Agilent 4644K human whole
genome microarray chips at the Genomics and Bioinformatics
Core of the University of North Carolina, Chapel Hill. Human
4644K whole genome microarray chips were purchased from
Agilent Technologies (Santa Clara, CA). HUVEC/Vector cells
and HUVEC/GPR4 cells were treated with pH 6.4 for 5 hours to
activate GPR4 or with pH 8.4 for 5 hours as a negative control.
After the pH treatment, total RNA was isolated using the RNeasy
Plus Mini Kit (QIAGEN, Valencia, CA) following the manufac-
turer’s protocol. RNA quality was assessed by electrophoresis using
the Agilent 2100 Bioanalyzer and the RNA samples of high
integrity number were used for microarray hybridization. Total
RNA from pH 6.4-treated HUVEC (vector or GPR4-overex-
pressing) cells was reverse transcribed and labeled with Cy5
fluorescent dye to serve as the test sample, whereas total RNA
from pH 8.4-treated HUVEC (vector or GPR4-overexpressing)
cells was reverse transcribed and labeled with Cy3 dye to serve as
the reference control. The same amount of labeled sample and
control cRNAs was hybridized to the 4644K Agilent Whole
Genome Microarray Chips. Hybridization signals were scanned
using an Agilent scanner. Microarray data were normalized
through LOWESS normalization and the fold of gene expression
change (log2 ratio of the mean red intensity over mean green
intensity) was analyzed using the software at the UNC Genomics
and Bioinformatics Core (https://genome.unc.edu/). Significance
analysis of microarrays (SAM) was used to identify genes whose
expression levels were significantly altered between pH 6.4 and
pH 8.4 treatments. The microarray data has been deposited to the
Gene Expression Omnibus (GEO) repository under the accession
number GSE40060.
Real-time RT-PCR
Human endothelial cells with endogenous or overexpressed
GPR4 levels were treated with indicated conditions. Total RNA
was extracted from these cells using the RNeasy Plus mini kit
(QIAGEN) and was reverse transcribed using the SuperScript II
reverse transcriptase (Invitrogen, CA). TaqMan pre-designed
primer-probes specific for target genes (Applied Biosystems) were
listed in the Table S1. The primer-probes for human GPR4 and
glyceraldehydes-3-phophate dehydrogenase (GAPDH) have been
previously described [13]. Real-time PCR was performed in
duplicate with a program of 50uC for 2 min, 95uC for 10 min
followed by 40 cycles of 95uC for 15 sec and 60uC for 1 min, and
the data was acquired and analyzed using the ABI 7300 or ABI
7900HT real-time PCR thermocycler. The fold of gene expression
changes was calculated using the 22DDCt method [22].
Western blotting
After indicated length of pH treatment, endothelial cells were
lysed in ice-cold radioimmune precipitation assay (RIPA) buffer as
previously described [13]. Protein concentration of cell lysate
supernatant was determined by the Bradford protein assay (Bio-
Rad, Hercules, CA) or the bicinchoninic acid (BCA) assay kit
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(Thermo Scientific). Cell lysates were then separated by SDS-
PAGE and transferred onto nitrocellulose membrane (GE
Healthcare). The expression of phosphorylated IkB-a, DDIT3
(CHOP), PTGS2 (COX-2) and GAPDH was analyzed by Western
blotting with corresponding primary antibodies and the horserad-
ish peroxidase (HRP)-conjugated secondary antibody (Santa Cruz
Biotechnology). Chemiluminescence signals were detected using
the Amersham ECL Advance Western blotting detection kit
according to the manufacturer’s instruction (GE Healthcare).
Intracellular cAMP measurement
The cAMP assay was performed as previously described [13].
Briefly, HUVEC/Vector or HUVEC/GPR4 cells were seeded at
a 2.56104 cells/well (100 ml) in a 96-well plate and allowed to
attach overnight. The following day old media were removed and
cells were pretreated for 10 minutes at 37uC in a tissue culture
incubator with the following conditions: EGM-2 or EGM-2 with
0.04% DMSO, 0.2 mM GPR4 antagonist, 2 mM GPR4 antago-
nist, or 20 mM GPR4 antagonist in a total volume of 100 ml per
well. After the pretreatment, media were removed and cells were
treated for 10 minutes at 37uC in a tissue culture incubator with
the following conditions: EGM-2/HEM buffered to pH 8.4,
pH 7.4, and pH 6.4, pH 6.4+0.04% DMSO, pH 6.4+0.2 mM
GPR4 antagonist, pH 6.4+2 mM GPR4 antagonist, and
pH 6.4+20 mM GPR4 antagonist. All treatment media contained
0.5 mM IBMX. After the pH treatment, intracellular cAMP was
measured using the Amersham cAMP Biotrak Enzymeimmunoas-
say (EIA) System (GE Healthcare Life Sciences Cat # RPN2251)
following the protocol provided by the manufacturer.
Flow chamber cell adhesion assay
HUVEC/Vector or HUVEC/GPR4 cells were cultured on 6-
cm plates that were pre-coated with 0.1% gelatin to form a
monolayer. Growth medium was then switched to EGM-2/HEM
media at pH 8.4, 7.4 or 6.4, and HUVECs were treated for
5 hours in the pH medium. A parallel plate flow chamber kit
(GlycoTech, Gaithersburg, MD) was used to perform dynamic
flow chamber assays according to the manufacturer’s protocol.
The plastic chamber was placed on to a rubber gasket which has
the thickness of 0.01 inches and a flow path width of 0.5 cm.
These dimensions allow for the cells to be flowed through the
chamber with a wall shear stress of 0.5 dyne/cm2 at a volumetric
flow rate of 0.2 ml/min. The flow chamber was connected to a
programmable syringe pump (Harvard Apparatus). Once the
chamber was set up, one plate of the treated HUVECs was washed
once with EGM-2, and then media were added on top of the
monolayer of HUVECs to keep them viable during the assay.
U937 monocytic cells (ATCC, Manassas, VA) at the concentration
of 16106 cells/ml were then flowed through the chamber for 5
minutes while video was taken. After 5 minutes of flowing, the
syringe containing the cells was removed and replaced with a
syringe containing warm RPMI+10% FBS. Cells were then
washed for another 3 to 5 minutes until all non-adhered cells were
removed. After the wash, still images of 3 fields of adherent U937
cells were taken for each treatment condition. Images were then
analyzed using Adobe Photoshop and adherent U937 cells were
counted (total 22.46magnification, approximately area of
1.2 mm2 per image). Static HUVEC-U937 cell adhesion was
performed as previously described [13], and attached U937 cells
from 3 fields were counted under an inverted microscope (total
1006 magnification, approximately area of 2.7 mm2 per 1006
field).
Statistical analysis
Data was analyzed using the GraphPad Prism 5 software. The
results of cAMP production, cell adhesion, and a substantial part
of real-time RT-PCR data points were derived from three or more
independent biological replicates, whereas some real-time RT-
PCR results were based on two independent biological replicates
with the same trend of gene expression and might have a limited
statistical power. P,0.05 (t test) was considered statistically
significant.
Supporting Information
Figure S1 HUVEC, HPAEC and HMVEC-L cells have
high expression level of GPR4. (A) Total RNA was isolated
from HUVEC, HPAEC or HMVEC-L parental cells, and cDNA
was synthesized. Gene expression of GPR4 family members in
those endothelial cells was examined by RT-PCR using gene-
specific primers. (B) Total RNA was isolated from HUVEC,
HPAEC or HMVEC-L parental cells, and cDNA was synthesized.
Gene expression of GPR4 in those cells was examined by real-time
RT-PCR. Ct values were normalized to the housekeeping gene
GAPDH. The expression level of GPR4 in HUVEC was set as 1.
Error bars indicate the mean 6 SEM. The expression data are
representative of two independent experiments.
(TIF)
Figure S2 Isocapnic acidosis increases the expression of
inflammatory genes in HPAEC and HMVEC-L. HPAEC
(white bars) or HMVEC-L (dark bars) parental cells were treated
with EGM-2/HEM or EGM-2-MV/HEM media at pH 8.4, 7.4,
or 6.4 for 5 h, respectively. Total RNA was isolated and cDNA
was synthesized. Real-time RT-PCR quantification of gene
expression of VCAM1 (A), SELE (B), ICAM1 (C), IL8 (D),
CXCL2 (E) and CCL20 (F) was performed in duplicate. Ct values
were normalized to the ones of housekeeping gene GAPDH. The
expression level of the target gene in HPAECs at pH 8.4 was set as
1. The results are representative of two independent experiments.
Error bars indicate the mean 6 SEM. *, P,0.05; **, P,0.01; ***,
P,0.001; ns, not significant (P.0.05); compared with the pH 8.4
groups.
(TIF)
Figure S3 Inhibition of NF-kB pathway attenuates the
expression of inflammatory genes. HUVECs stably over-
expressing GPR4 were treated for 5 h with EGM-2/HEM
pH 8.4, 7.4 or 6.4 media, or with pH 6.4 media containing
indicated concentrations of IKK inhibitor VII. Real-time RT-
PCR quantification of gene expression of VCAM1 (A), SELE (B),
ICAM1 (C), IL8 (D), CXCL2 (E) and CCL20 (F) was performed in
duplicate. Ct values were normalized to the housekeeping gene
GAPDH. The expression level of the target gene in HUVEC/
GPR4 cells at pH 8.4 was set as 1. Error bars indicate the mean 6
SEM. *, P,0.05; **, P,0.01; ***, P,0.001; ns, not significant
(P.0.05); compared with the pH 6.4 vehicle groups. The results
are representative of two independent experiments.
(TIF)
Table S1 A list of TaqMan pre-designed primer-probes
used in the study.
(DOC)
Table S2 A list of 1208 differentially expressed genes
regulated by acidosis/GPR4 (values are expressed as
log2).
(XLS)
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Table S3 SAM analysis of genes that were induced by
GPR4 overexpression in HUVECs.
(XLSX)
Table S4 SAM analysis of genes that were repressed by
GPR4 overexpression in HUVECs.
(XLSX)
Table S5 Table of Gene Ontology enrichment generated
by GATHER using the GPR4 overexpression-induced
genes from Table S3.
(XLSX)
Table S6 Table of Gene Ontology enrichment generated
by GATHER using the GPR4 overexpression-repressed
genes from Table S4.
(XLSX)
Table S7 Fold changes of gene expression by real-time
RT-PCR in HUVEC/Vector and HUVEC/GPR4 cells
upon varying pH treatment.
(DOC)
Video S1 Adhesion of U937 monocytes to HUVEC/
Vector cells that were treated with pH 8.4. Adhesion of
U937 monocytes to pH-treated HUVECs under a flow condition
was performed as described in the ‘‘Materials and Methods’’. A
15-second video clip of the HUVEC-U937 cell adhesion is
presented.
(AVI)
Video S2 Adhesion of U937 monocytes to HUVEC/
Vector cells that were treated with pH 7.4.
(AVI)
Video S3 Adhesion of U937 monocytes to HUVEC/
Vector cells that were treated with pH 6.4.
(AVI)
Video S4 Adhesion of U937 monocytes to HUVEC/
GPR4 cells that were treated with pH 8.4.
(AVI)
Video S5 Adhesion of U937 monocytes to HUVEC/
GPR4 cells that were treated with pH 7.4.
(AVI)
Video S6 Adhesion of U937 monocytes to HUVEC/
GPR4 cells that were treated with pH 6.4.
(AVI)
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